Page last updated: 2024-10-25

debrisoquin and Tetanus

debrisoquin has been researched along with Tetanus in 1 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Tetanus: A disease caused by tetanospasmin, a powerful protein toxin produced by CLOSTRIDIUM TETANI. Tetanus usually occurs after an acute injury, such as a puncture wound or laceration. Generalized tetanus, the most common form, is characterized by tetanic muscular contractions and hyperreflexia. Localized tetanus presents itself as a mild condition with manifestations restricted to muscles near the wound. It may progress to the generalized form.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hörtnagl, H1
Hammerle, AF1
Hackl, JM1

Other Studies

1 other study available for debrisoquin and Tetanus

ArticleYear
[Hypermetabolism in head injury and tetanus: patho-physiological and new therapeutic conceptions].
    Infusionstherapie und klinische Ernahrung, 1980, Volume: 7, Issue:6

    Topics: Adrenergic beta-Antagonists; Catecholamines; Craniocerebral Trauma; Debrisoquin; Drug Therapy, Combi

1980